Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.51.3
PrivacidadTérminosCookiesAviso Legal
● Connected
BDMD US Equity
Baird Medical Investment Holdings Ltd
0.60USD▼ 12.38%
Healthcare
Medical Devices
96)Comparar97)Tesis →
Market Cap
$19M
Shares Outstanding
32M
— Annual —FY2025
Revenue
$23M
Gross Margin
83.8%
Operating Margin
-113.7%
Net Margin
-121.0%
FCF Margin
-6.2%
ROE
-87.0%
ROCE
-68.7%
Net Debt/EBITDA
-0.3×
Current Ratio
1.7
D/E Ratio
0.28
FCF / Share
-0.04
Book Value / Share
0.98
BDMD US Equity
0.60USD▼ 12.38%
Tesis →

Baird Medical Investment Holdings Ltd (BDMD): análisis fundamental y valoración

Baird Medical Investment Holdings Ltd cotiza a 0.60 USD y tiene una capitalización bursátil de $19M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNasdaqPaísChinaEmpleados146Beta-1.12Web↗ bairdmed.com

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needl…

Múltiplos de Valoración
P/E (Annual)
—
P/E (TTM)
—
P/FCF (Annual)
—
P/FCF (TTM)
—
EV/EBITDA
—
EV/Revenue
1.2×
P/Sales
0.9×
P/Book
0.6×
Rentabilidad (Último Anual)
Gross Margin
83.8%
Operating Margin
-113.7%
Net Margin
-121.0%
FCF Margin
-6.2%
ROE
-87.0%
ROCE
-68.7%
ROA
-39.1%
Effective Tax Rate
—
Métricas TTM
Revenue TTM
—
Gross Profit TTM
—
Operating Income TTM
—
Net Income TTM
—
FCF TTM
—
EPS TTM
—
Quarters Used
—
TTM Period
—
Solidez del Balance
Net Debt
$9M
Net Debt / EBITDA
-0.3×
Debt / Equity
0.28
Current Ratio
1.7
Interest Coverage
-66.9×
Working Capital
$23M
Book Value / Share
0.98
Net Debt / Share
0.27
Crecimiento (YoY)
Revenue YoY
-39.1%
Net Income YoY
-319.0%
FCF YoY
+84.9%
EPS Diluted YoY
-300.0%
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
-0.04
CapEx % Revenue
0.2%
Rev / Employee
154,363
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaBDMDMediana SectorΔ
Gross Margin83.8%57.0%+26.8%
Operating Margin-113.7%-38.6%-75.1%
Net Margin-121.0%-33.6%-87.5%
FCF Margin-6.2%-13.9%+7.7%
ROE-87.0%-40.4%-46.6%
ROA-39.1%-32.0%-7.1%
Current Ratio1.702.84-1.14
Debt / Equity0.280.280.00
Scoring Fundamental
Piotroski F-Score
1/ 9Débil
✗F1ROA positivo (rentabilidad activos)
✗F2Flujo caja operativo positivo
✗F3ROA mejora vs año anterior
✓F4Calidad de beneficios (OCF > ROA)
✗F5Apalancamiento baja
✗F6Liquidez mejora (current ratio)
✗F7Sin dilución accionarial
✗F8Margen bruto mejora
✗F9Rotación activos mejora
Altman Z-ScoreZona de Riesgo
-0.20
x1_working_capital0.324
x2_retained_earnings-0.007
x3_ebit-0.368
x4_market_equity0.517
x5_sales0.323
>2.99 segura · 1.81–2.99 gris · <1.81 riesgo
Capital Allocation
2/ 8Débil
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✗DilucSin dilución significativa (< 2%/año en 3 años)
✗Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✓DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✗Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)
Histórico Piotroski F-Score
Histórico de Múltiplos